Capecitabine plus oxaliplatin (xelox) in the treatment of chemotherapy-naive patients with metastatic colorectal cancer

By Yaman Emel   Uner Aytug   Er Ozlem   Coskun Ugur   Buyukberber Suleyman   Dikilitas Mustafa   Polat Mevlude   Yamac Deniz   Kaya Ali   Yildiz Ramazan   Ozturk Banu   Benekli Mustafa  

Medical Oncology, Vol. 24, Iss. 4, 2007-12 ,pp. : 431-435

Humana Press, Inc

Access to resources Recommend Favorite

Chronomodulated administration of oxaliplatin plus capecitabine (XELOX) as first line chemotherapy in advanced colorectal cancer patients: phase II study

By Santini Daniele   Vincenzi Bruno   Schiavon Gaia   Di Seri Marisa   Virzí Vladimir   Spalletta Bruno   Caricato Marco   Coppola Roberto   Tonini Giuseppe  

Cancer Chemotherapy and Pharmacology, Vol. 59, Iss. 5, 2007-04 ,pp. : 613-620

Springer Publishing Company

Access to resources Recommend Favorite

First-line chemotherapy with docetaxel plus capecitabine followed by capecitabine or hormone maintenance therapy for the treatment of metastatic breast cancer patients

By  

Oncology Letters, Vol. 9, Iss. 2, 2015-01 ,pp. : 987-993

Spandidos Publications

Access to resources Recommend Favorite

A phase II study of capecitabine plus oxaliplatin (XELOX): A new first-line option in metastatic colorectal cancer

By Makatsoris Thomas   Kalofonos Haralabos   Aravantinos Gerasimos   Papadimitriou Christos   Kastritis Efstathios   Rigatos Sotirios   Xiros Nikolaos   Petsas Theodore   Economopoulos Theofanis   Sakadamis Athanassios   Fountzilas George  

International Journal of Gastrointestinal Cancer, Vol. 35, Iss. 2, 2005-04 ,pp. : 103-109

Humana Press, Inc

Access to resources Recommend Favorite

Hypertriglyceridemia in patients with metastatic breast cancer and treatment with capecitabine

By Geva Shahar   Lazarev Irena   Geffen David Barry   Ariad Samuel  

Journal of Chemotherapy, Vol. 25, Iss. 3, 2013-06 ,pp. : 176-180

Maney Publishing

Access to resources Recommend Favorite